21 reports

The infectious disease testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade.

  • Infectious Disease
  • Pathology
  • Brazil
  • Market Size

Market Segmentation Analysis - Test volume and sales forecasts for over ## blood typing, grouping and infectious disease screening tests, including NAT.

  • Infectious Disease
  • Molecular Diagnostics
  • Pathology
  • Brazil

Market Segmentation Analysis - Test volume and sales forecasts for over ## blood typing, grouping and infectious disease screening tests, including NAT.

  • Infectious Disease
  • Molecular Diagnostics
  • Pathology
  • Brazil
  • BECTON, DICKINSON AND COMPANY SUMMARY
  • ALERE

The initial screening of infectious diseases has created a growing opportunity for POC infectious disease tests, which are currently worth roughly $## million.

  • Infectious Disease
  • Brazil
  • Alere Inc.
  • Becton Property Group
  • bioMerieux S.A.

BIOMERIEUX PRODUCTS ARE USED DIAGNOSING AND MANAGING INFECTIOUS DISEASES, CARDIOVASCULAR DISEASES AND TARGETED CANCERS.

  • Infectious Disease
  • Brazil
  • Alere Inc.
  • bioMerieux S.A.
  • Hologic, Inc.

BIOMERIEUX PRODUCTS ARE USED DIAGNOSING AND MANAGING INFECTIOUS DISEASES, CARDIOVASCULAR DISEASES AND TARGETED CANCERS.

  • Infectious Disease
  • Brazil
  • Forecast
  • Market Size
  • QIAGEN N.V.
  • MERCK'S HCV PORTFOLIO ASSESSMENT, 2016
  • HIGHLIGHTS MERCK'S PORTFOLIO OF MARKETED AND PIPELINE PRODUCTS INDICATED FOR HCV.

CLINICAL INFECTIOUS DISEASES; ##(##): ##-##.

  • Infectious Disease
  • Brazil
  • Market Size
  • AbbVie Inc.
  • Gilead Sciences, Inc.

The infectious disease testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade.

  • Infectious Disease
  • Pathology
  • Brazil
  • Market Size

High prevalence of endemic infectious disease along with positive potential for emergence of new diseases like Ebola make infectious disease testing another segment of prime activity in Latin America point of care market.

  • Infectious Disease
  • Pathology
  • Point Of Care Testing
  • Brazil
  • Forecast

Market Segmentation Analysis - Test volume and sales forecasts for over ## blood typing, grouping and infectious disease screening tests, including NAT.

  • Hepatitis
  • Infectious Disease
  • Molecular Diagnostics
  • Pathology
  • Brazil

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY; ##(##): ##-##.

  • Infectious Disease
  • Brazil
  • Western Europe
  • Market Size
  • Novartis AG

Market Segmentation Analysis - Volume and sales forecasts for over ## infectious disease assays by individual test. - Test volume estimates by method (molecular, serology/ immunodiagnostics, culture/ microscopy).

  • Infectious Disease
  • Pathology
  • Brazil

Drugs, on average, take ##. ## years from Phase I to approval, compared to ##. ## years in the overall infectious disease space.

  • Infectious Disease
  • Pathology
  • Brazil
  • United States

Brazilian Journal of Infectious Diseases; ##(##): ##-##.

  • Hepatitis
  • Infectious Disease
  • Pathology
  • Brazil
  • Forecast

Journal of the Pediatric Infectious Diseases Society; ##(##): ##-##.

  • Health Services
  • Infectious Disease
  • Laboratory
  • Brazil
  • Forecast

The pharmaceutical segment produces and markets products in five therapeutic areas, including immunology (rheumatoid arthritis, inflammatory bowel disease, psoriasis and pulmonary diseases), infectious diseases (human immunodeficiency virus (HIV), hepatitis, respi

  • Infectious Disease
  • Therapy
  • Brazil
  • GlaxoSmithKline plc
  • Johnson & Johnson

Market Segmentation Analysis - Test volume and sales forecasts for over ## blood typing, grouping and infectious disease screening tests, including NAT.

  • Infectious Disease
  • Molecular Diagnostics
  • Pathology
  • Brazil

Market Segmentation Analysis - Test volume and sales forecasts for over ## blood typing, grouping and infectious disease screening tests, including NAT.

  • Infectious Disease
  • Molecular Diagnostics
  • Pathology
  • Brazil

Dengue vaccines

4385 5000 3900
  • TETRAVAX-DV DRUG PROFILE
  • TETRAVAX-DV PRICE ASSUMPTIONS

The Journal of Infectious Diseases, ##(suppl ##), S##−## < DOI> ##. ##/ infdis/ jir##< / DOI>.

  • Infectious Disease
  • Brazil
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Takeda Pharmaceutical Company Limited
  • 14.2.1 OCT 25, 2017: PREGNANT WOMEN SHOULD BE TESTED MORE THAN ONCE FOR THE PRESENCE OF ZIKA

THE RESULTS WILL BE PUBLISHED IN NOVEMBER IN THE JOURNAL EMERGING INFECTIOUS DISEASES.

  • Genetic Testing
  • Infectious Disease
  • Brazil
  • Forecast
  • QIAGEN N.V.
  • GLOBAVIR ENTERS INTO CO-DEVELOPMENT AGREEMENT WITH BIOMANGUINHOS
  • GENCELL BIOSYSTEMS TO ENTER INTO AGREEMENT WITH FIOCRUZ, INSTITUTE OF MOLECULAR BIOLOGY OF PARANA AND IMMUNOBIOLOGICAL TECHNOLOGY INSTITUTE TO DEVELOP CLINICAL SCREENING SYSTEMS

WRAIR hosts the centers for military psychiatry and neuroscience research and for infectious disease research.

  • Infectious Disease
  • Brazil
  • Company Operations
  • Deals & Alliance
  • Supply